Jiuzhitang Co. Hits Day Low of CNY 8.95 Amid Price Pressure

Jiuzhitang Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 6.52% on July 17, 2026, hitting an intraday low of CNY 8.95. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Despite today's downturn, Jiuzhitang has shown resilience over the past week, with a gain of 10.66%, and a solid monthly performance of 14.89%. However, the stock has faced challenges over the longer term, with a year-to-date increase of 3.44%, yet a significant decline of 24.18% over the past year. Financially, Jiuzhitang reported impressive growth metrics, including a net profit increase of 132.1% and a return on equity (ROE) of 8.73%. The company also boasts a high dividend yield of 4.99% and a price-to-book ratio of 1.33, indicating an attractive valuation. As the company continues to navigate market fluctuations, its recent financial results highlight a mix of potential and challenges within the competitive landscape.